Trial Profile
Phase II investigation of topotecan and Taxol [paclitaxel] in patients with recurrent/metastatic cancer of the cervix
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Topotecan (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 02 Oct 2005 New trial record.